Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

About the Journal of Invasive Cardiology

 

The Journal of Invasive Cardiology 70 East Swedesford Road, Suite 100 Malvern, PA 19355 Phone: 800-237-7285 Phone: 610-560-0500 Fax: 610-560-0502.  

ISSN: 1557-2501

CLOCKSS

Aims and Purpose:

Journal of Invasive Cardiology (JIC) is a peer-reviewed scientific medical journal serving clinicians who treat cardiovascular disease. JIC provides clinicians with the information critical to keeping up with the dramatic changes and technologic innovations in diagnosing and treating patients with cardiovascular disease using non-surgical treatment modalities.

2024 Impact Factor: 1.6

View Our Editorial Board here

For information regarding journal content or writing for the Journal of Invasive Cardiology, please contact the following people:

Editorial

Laura Simson
Executive Editor
lsimson@hmpglobal.com

Isabel Vega 
Associate Digital Editor
ivega@hmpglobal.com

Production

Elizabeth Vasil
Layout/Production Manager, (800) 237-7285, ext. 4239
evasil@hmpglobal.com

Business Staff

For information regarding advertising in the Journal of Invasive Cardiology, contact one of the following:

Joshua D. Hartman, Senior Vice President, Cardiovascular & Public Safety Divisions
Tel: (302) 786-6231, email jhartman@hmpglobal.com

Colleen Waters, Associate Vice President, US Cardiovascular Division
Tel: (609) 630-6203, email cwaters@hmpglobal.com

Carson McGarrity, Director, National Accounts, US Cardiovascular Division
Tel: (215) 262-4739, email cmcgarrity@hmpglobal.com

Stephanie Starman, Senior Manager, National Accounts, US Cardiovascular Division
Tel: (800) 237-7285, ext. 4118, email sstarman@hmpglobal.com

 

Advertising Policy
Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of HMP Global, the editorial staff, or any member of the editorial advisory board. HMP Global is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement or approval of the products or services advertised or of their effectiveness, quality or safety. Rapid advances in medicine may cause information contained here to become outdated, invalid or subject to debate. Accuracy cannot be guaranteed. HMP Global disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.

For classified advertising, visit www.healthjobconnect.com for more information.

For more information, please visit our online sales portal.

About HMP Global

HMP Global is the omnichannel market leader in healthcare events, education, and insight — with a mission to improve patient care. For 40 years, the company has built trusted brands including Psych Congress, the premier source for mental health education, and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. HMP Global partners with leading experts around the world to deliver more than 450 annual events, medical strategy, and marketing for pharmaceutical and medical device customers through HMP Collective, and pharmaceutical market insight, engaging a global community of healthcare stakeholders that includes nearly 2 million clinicians across 600 medical specialties as well as managed care, behavioral health, senior living, emergency medical, and pharmaceutical commercialization professionals. For more information, follow HMP Global on LinkedIn or visit hmpglobal.com.

HMP Omnimedia
70 E. Swedesford Rd., Ste. 100
Malvern, PA 19355

Advertisement

Advertisement

Advertisement

News

Structural Heart
Medtronic Begins Multicenter Study to Address Health Disparities in Structural Heart Disease Care
11/20/2024
The study will utilize the Tempus Next platform to identify severe aortic stenosis or moderate to severe mitral regurgitation patients who meet guideline indicated therapy criteria, but do not have a treatment plan in place.
The study will utilize the Tempus Next platform to identify severe aortic stenosis or moderate to severe mitral regurgitation patients who meet guideline indicated therapy criteria, but do not have a treatment plan in place.
The study will utilize the...
11/20/2024
Cath Lab Digest
News
Double Win With Bridging Stents: FEVAR Certifications for BeGraft and BeFlared
11/20/2024
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024....
11/20/2024
Vascular Disease Management
Heart research
Study: Genetic Information Related to Heart Shape Can Provide Risk Score for Heart Disease
11/18/2024
"We've long known that size and volume of the heart matter, but by examining shape, we're uncovering new insights into genetic risks," said study co-author Professor Patricia B. Munroe. Researchers are the first to examine the genetic basis...
"We've long known that size and volume of the heart matter, but by examining shape, we're uncovering new insights into genetic risks," said study co-author Professor Patricia B. Munroe. Researchers are the first to examine the genetic basis...
"We've long known that size and...
11/18/2024
Cath Lab Digest
Coronary Calcium Scores
Intermountain Health Study Finds Prognostic Value of Coronary Calcium Scores Effective in Predicting Risk of Heart Attack
11/18/2024
A major new study by Intermountain Health researchers finds coronary artery calcium scores are not only highly effective in identifying those at risk for future heart attacks, but also for death, and risk prediction was found to be as good in...
A major new study by Intermountain Health researchers finds coronary artery calcium scores are not only highly effective in identifying those at risk for future heart attacks, but also for death, and risk prediction was found to be as good in...
A major new study by...
11/18/2024
Cath Lab Digest
spironolactone
CLEAR SYNERGY Trial: Spironolactone May Reduce Heart Failure Risk But Did Not Significantly Impact Rate of Death, New Heart Attack, or Stroke
11/18/2024
“While spironolactone didn’t reduce deaths or other major heart complications after a heart attack, it did reduce the likelihood of heart failure, which is an important finding for patients and health care professionals," said Sanjit Jolly,...
“While spironolactone didn’t reduce deaths or other major heart complications after a heart attack, it did reduce the likelihood of heart failure, which is an important finding for patients and health care professionals," said Sanjit Jolly,...
“While spironolactone didn’t...
11/18/2024
Cath Lab Digest
Patient Care
AHA: Fear of Another Heart Attack May Be Major Source of Ongoing Stress for Survivors
11/18/2024
The researchers suggest that fear of another heart attack should be evaluated and addressed separately from depression and anxiety. In the survey, the fear of another heart attack was significant at 6 months after the heart attack and still...
The researchers suggest that fear of another heart attack should be evaluated and addressed separately from depression and anxiety. In the survey, the fear of another heart attack was significant at 6 months after the heart attack and still...
The researchers suggest that...
11/18/2024
Cath Lab Digest
Sex Differences
JAMA Network Open: First Extensive Investigation of Sex-Specific Differences in Cerebral Small Vessel Disease
11/18/2024
Men are more frequently affected by cerebral microbleeds (CMBs)—around 28% of patients had at least one microbleeding event, whereby the prevalence in men was significantly higher than in women. In contrast, women appeared to suffer damage to...
Men are more frequently affected by cerebral microbleeds (CMBs)—around 28% of patients had at least one microbleeding event, whereby the prevalence in men was significantly higher than in women. In contrast, women appeared to suffer damage to...
Men are more frequently affected...
11/18/2024
Cath Lab Digest
Kidney Transpant & CVD/Stroke Risk
Innovative Risk Score Accurately Calculates Which Kidney Transplant Candidates Are Also at Risk for Heart Attack or Stroke, Intermountain Health Study Finds
11/18/2024
Using an innovative risk score assessment score, heart researchers at Intermountain Health in Salt Lake City say they can accurately predict whether patients being assessed for kidney transplant will likely have a future major cardiac event,...
Using an innovative risk score assessment score, heart researchers at Intermountain Health in Salt Lake City say they can accurately predict whether patients being assessed for kidney transplant will likely have a future major cardiac event,...
Using an innovative risk score...
11/18/2024
Cath Lab Digest
Inflammation
AHA: Air Pollution Increases Inflammation Primarily in Patients With Heart Disease
11/18/2024
"Individuals with known heart disease, including those diagnosed with heart failure, need to be especially cautious during periods of poor air quality. This includes exercising indoors, making sure to take their prescribed medications, and...
"Individuals with known heart disease, including those diagnosed with heart failure, need to be especially cautious during periods of poor air quality. This includes exercising indoors, making sure to take their prescribed medications, and...
"Individuals with known heart...
11/18/2024
Cath Lab Digest
Bleeding Reduction
AHA: AZALEA-TIMI 71 Study Demonstrates Factor XI Inhibitor Abelacimab Substantially Reduced Bleeding in Patients on Antiplatelet Therapy Compared to Rivaroxaban
11/18/2024
"Given the elevated bleeding risks associated with traditional anticoagulants, particularly when combined with antiplatelet agents, abelacimab may offer a safer alternative for patients with atrial fibrillation,” said Christian T. Ruff, MD,...
"Given the elevated bleeding risks associated with traditional anticoagulants, particularly when combined with antiplatelet agents, abelacimab may offer a safer alternative for patients with atrial fibrillation,” said Christian T. Ruff, MD,...
"Given the elevated bleeding...
11/18/2024
Cath Lab Digest

Advertisement

Advertisement

Diabetes and Heart Disease
Proactively Screening Diabetics for Heart Disease Does Not Improve Long-term Mortality Rates or Reduce Future Cardiac Events, New Study Finds
11/20/2024
“Our study found that doing these kinds of screenings on patients doesn’t make any marked difference in their long-term survival rates,” said J. Brent Muhlestein, principal investigator of the study and co-director of cardiovascular research...
“Our study found that doing these kinds of screenings on patients doesn’t make any marked difference in their long-term survival rates,” said J. Brent Muhlestein, principal investigator of the study and co-director of cardiovascular research...
“Our study found that doing...
11/20/2024
Cath Lab Digest
Ku Figure
Clinical Videos
Giant Traumatic External Iliac Artery-Femoral Arteriovenous Fistula
11/20/2024
Video Supplement to "Giant Traumatic External Iliac Artery-Femoral Arteriovenous Fistula" (Clinical Image).
Video Supplement to "Giant Traumatic External Iliac Artery-Femoral Arteriovenous Fistula" (Clinical Image).
Video Supplement to "Giant...
11/20/2024
Journal of Invasive Cardiology
Clinical Images
Giant Traumatic External Iliac Artery-Femoral Arteriovenous Fistula
11/20/2024
A 53-year-old woman presented with shortness of breath and fatigue for 1 week. The patient had a medical history of left thigh trauma for more than 20 years.
A 53-year-old woman presented with shortness of breath and fatigue for 1 week. The patient had a medical history of left thigh trauma for more than 20 years.
A 53-year-old woman presented...
11/20/2024
Journal of Invasive Cardiology
Structural Heart
Medtronic Begins Multicenter Study to Address Health Disparities in Structural Heart Disease Care
11/20/2024
The study will utilize the Tempus Next platform to identify severe aortic stenosis or moderate to severe mitral regurgitation patients who meet guideline indicated therapy criteria, but do not have a treatment plan in place.
The study will utilize the Tempus Next platform to identify severe aortic stenosis or moderate to severe mitral regurgitation patients who meet guideline indicated therapy criteria, but do not have a treatment plan in place.
The study will utilize the...
11/20/2024
Cath Lab Digest
News
Double Win With Bridging Stents: FEVAR Certifications for BeGraft and BeFlared
11/20/2024
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024....
11/20/2024
Vascular Disease Management
Original Contribution
Left Atrial Appendage Occlusion in Patients With Non-Valvular Atrial Fibrillation and Cerebral Amyloid Angiopathy
11/19/2024
The aim of this LOGIC (Left atrial appendage Occlusion in patients with Gastrointestinal or IntraCranial bleeding) registry sub-study was to investigate the safety and efficacy of left atrial appendage occlusion in patients with non-valvular...
The aim of this LOGIC (Left atrial appendage Occlusion in patients with Gastrointestinal or IntraCranial bleeding) registry sub-study was to investigate the safety and efficacy of left atrial appendage occlusion in patients with non-valvular...
The aim of this LOGIC (Left...
11/19/2024
Journal of Invasive Cardiology
Review
Update on the Diagnosis and Treatment of Coronary Complications of Percutaneous Coronary Interventions
11/18/2024
The authors summarize studies on percutaneous coronary intervention complications, including coronary dissection, no reflow, perforation, and equipment loss/entrapment.
The authors summarize studies on percutaneous coronary intervention complications, including coronary dissection, no reflow, perforation, and equipment loss/entrapment.
The authors summarize studies on...
11/18/2024
Journal of Invasive Cardiology
Clinical Images
A Precise Endomyocardial Biopsy Method Guided by the Electroanatomical Mapping System
11/18/2024
The authors report a precise endomyocardial biopsy procedure in a patient with unexplained heart failure under guidance of an electroanatomical mapping system, which can avoid the complications of cardiac tamponade and arrhythmias.
The authors report a precise endomyocardial biopsy procedure in a patient with unexplained heart failure under guidance of an electroanatomical mapping system, which can avoid the complications of cardiac tamponade and arrhythmias.
The authors report a precise...
11/18/2024
Journal of Invasive Cardiology
Arrivi Figure
Clinical Videos
Cardiac Rupture Following Myocardial Infarction With Non-Obstructive Coronary Artery Disease
11/18/2024
Video Supplement to "Cardiac Rupture Following Myocardial Infarction With Non-Obstructive Coronary Artery Disease" (Clinical Image).
Video Supplement to "Cardiac Rupture Following Myocardial Infarction With Non-Obstructive Coronary Artery Disease" (Clinical Image).
Video Supplement to "Cardiac...
11/18/2024
Journal of Invasive Cardiology
Clinical Images
Cardiac Rupture Following Myocardial Infarction With Non-Obstructive Coronary Artery Disease
11/18/2024
A 71-year-old man with a history of smoking presented to the emergency room of our hospital complaining of long-lasting angina symptoms. Upon physical examination, he was hypotensive.
A 71-year-old man with a history of smoking presented to the emergency room of our hospital complaining of long-lasting angina symptoms. Upon physical examination, he was hypotensive.
A 71-year-old man with a history...
11/18/2024
Journal of Invasive Cardiology

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement